首页> 外文学位 >Avian sarcoma and leukosis viral entry mechanism and its inhibition by small molecules.
【24h】

Avian sarcoma and leukosis viral entry mechanism and its inhibition by small molecules.

机译:禽肉瘤和白血病的病毒进入机制及其对小分子的抑制作用。

获取原文
获取原文并翻译 | 示例

摘要

Avian Sarcoma and Leukosis Viruses (ASLVs) are used as a retroviral model system to study mechanisms of envelope-receptor interactions, virus-cell membrane fusion, viral endocytosis, and intracellular virus-cell interactions. Studies of ASLV may lead to an improved understanding of HIV pathogenesis and the use of retroviruses as vectors for targeted gene therapy.;This dissertation describes studies in three major areas: Identification of the functional determinants in TVB, the receptor for ASLV subgroup B; the mechanism of cell binding and internalization when ASLV infection is mediated by a soluble receptor; and the identification of small molecule inhibitors of early steps of ASLV infection through high throughput screening.;A linear peptide encompassing amino acids 32--46 of TVB was shown to bind to subgroup B Env and was able to act as a minimal retroviral receptor that enabled viruses loaded with the peptide to infect receptor-negative cells. Key residues for the function of TVB32--46 were identified, and TVB32--46-mediated ASLV-B infection was shown to be absolutely dependent on a low pH intracellular environment, akin to ASLV infection mediated by membrane anchored receptors.;ASLV-B binding to cell surfaces was shown to be enhanced by the presence of TVB32--46, and heparan sulfate proteoglycans were shown to play an important role in soluble receptor peptide-mediated infection, which occurs with very slow kinetics through a pathway that was independent of clathrin-mediated endocytosis. These studies, combined with those undertaken by others, have revealed that ASLV can infect cells through distinct internalization pathways.;Finally, a library of small molecules was screened for inhibitors of early steps of ASLV entry in order to characterize cell factors required for ASLV entry, and for the potential development of novel antiretroviral agents. Several lead compounds were identified that inhibit both ASLV and HIV at multiple early steps in the entry lifecycle. Together, these studies have shed light on ASLV Env-receptor interactions and several aspects of the cell biology of ASLV infection.
机译:禽肉瘤和白血病病毒(ASLV)用作逆转录病毒模型系统,以研究包膜-受体相互作用,病毒-细胞膜融合,病毒内吞和细胞内病毒-细胞相互作用的机制。 ASLV的研究可能会导致人们对HIV发病机理的进一步了解以及逆转录病毒作为靶向基因治疗的载体的应用。本论文描述了三个主要领域的研究:TVB中功能决定簇的鉴定,TVB是ASLV B亚型的受体。当可溶性受体介导ASLV感染时,细胞结合和内在化的机制;并通过高通量筛选来鉴定ASLV感染早期阶段的小分子抑制剂。;包含TVB氨基酸32--46的线性肽显示与B亚群Env结合,并能够作为最小的逆转录病毒受体使装有该肽的病毒能够感染受体阴性细胞。鉴定出TVB32--46功能的关键残基,并显示TVB32--46介导的ASLV-B感染绝对依赖于低pH细胞内环境,类似于膜锚定受体介导的ASLV感染。通过TVB32--46的存在,B与细胞表面的结合被增强,硫酸乙酰肝素蛋白聚糖被证明在可溶性受体肽介导的感染中起着重要作用,而这种动力学以非常缓慢的动力学方式通过独立的途径发生网格蛋白介导的内吞作用。这些研究与其他人进行的研究相结合,揭示了ASLV可以通过不同的内在化途径感染细胞。;最后,筛选了一个小分子文库以寻找ASLV进入早期步骤的抑制剂,以表征ASLV进入所需的细胞因子,以及潜在的新型抗逆转录病毒药物的开发。在进入生命周期的多个早期步骤中,鉴定出了几种抑制ASLV和HIV的先导化合物。总之,这些研究为ASLV Env-受体相互作用以及ASLV感染的细胞生物学的某些方面提供了启示。

著录项

  • 作者

    Knauss, Daniel J.;

  • 作者单位

    The University of Wisconsin - Madison.;

  • 授予单位 The University of Wisconsin - Madison.;
  • 学科 Biology Microbiology.;Biology Cell.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 144 p.
  • 总页数 144
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号